Healthcare -
Biotechnology - NASDAQ - US
$ 1.82
-1.09 %
$ 382 M
Market Cap
-1.17
P/E
ALLO - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities ALLO - Allogene Therapeutics, Inc.
95.7 M
LAST VALUE
182.83%
2 YEAR CAGR
-34.12%
5 YEAR CAGR
0.00%
10 YEAR CAGR